Quest Diagnostics
DGX
#1095
Rank
C$28.24 B
Marketcap
C$252.55
Share price
-0.91%
Change (1 day)
13.60%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total debt

Total debt on the balance sheet as of September 2025 : C$8.83 Billion

According to Quest Diagnostics 's latest financial reports the company's total debt is C$8.83 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Quest Diagnostics - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$10.16 B39.46%
2023-12-31C$7.29 B14%
2022-12-31C$6.39 B5.16%
2021-12-31C$6.08 B-0.78%
2020-12-31C$6.13 B-13.33%
2019-12-31C$7.07 B30.11%
2018-12-31C$5.43 B12.17%
2017-12-31C$4.84 B-4.18%
2016-12-31C$5.05 B-0.13%
2015-12-31C$5.06 B16.63%
2014-12-31C$4.34 B22.43%
2013-12-31C$3.54 B6.03%
2012-12-31C$3.34 B-18.29%
2011-12-31C$4.09 B36.98%
2010-12-31C$2.98 B-8.58%
2009-12-31C$3.26 B-12.79%
2008-12-31C$3.74 B6.13%
2007-12-31C$3.53 B94.98%
2006-12-31C$1.81 B-2.27%
2005-12-31C$1.85 B40.46%
2004-12-31C$1.31 B-7.73%
2003-12-31C$1.43 B10.1%
2002-12-31C$1.29 B-0.76%
2001-12-31C$1.30 B-14.85%
2000-12-31C$1.53 B-12.41%
1999-12-31C$1.75 B145.59%
1998-12-31C$0.71 B-2.84%
1997-12-31C$0.73 B0.23%
1996-12-31C$0.73 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
LabCorp
LH
C$9.03 B 2.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
C$1.61 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
C$0.56 B-93.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C$4.15 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
C$2.94 B-66.67%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands